TY - JOUR
T1 - Allergic sensitization
T2 - Screening methods
AU - Ladics, Gregory S.
AU - Fry, Jeremy
AU - Goodman, Richard
AU - Herouet-Guicheney, Corinne
AU - Hoffmann-Sommergruber, Karin
AU - Madsen, Charlotte B.
AU - Penninks, André
AU - Pomés, Anna
AU - Roggen, Erwin L.
AU - Smit, Joost
AU - Wal, Jean Michel
N1 - Funding Information:
Evaluation of the sensitizing potential of industrial enzymes using the results from Sens-it-iv, a project funded by EU Framework Programme 6
Funding Information:
The authors gratefully acknowledge the contributions of all speakers and participants for their useful presentations and discussions at the April 2012 Symposium on Sensitizing Properties of Proteins. (Presentations can be viewed at http://www.hesiglobal.org/i4a/pages/index.cfm?pageid=3595.) Appreciation is extended to the HESI Protein Allergenicity Technical Committee (http://www.hesiglobal.org/i4a/pages/index.cfm?pageid=3317) for providing financial resources for the symposium. Research on the structure of allergen-antibody complexes (Figure 1) was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number R01AI077653 (to AP). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Publication charges for this article were funded by the ILSI Health and Environmental Sciences Institute.
Publisher Copyright:
© 2014 Ladics et al.
PY - 2014/4/15
Y1 - 2014/4/15
N2 - Experimental in silico, in vitro, and rodent models for screening and predicting protein sensitizing potential are discussed, including whether there is evidence of new sensitizations and allergies since the introduction of genetically modified crops in 1996, the importance of linear versus conformational epitopes, and protein families that become allergens. Some common challenges for predicting protein sensitization are addressed: (a) exposure routes; (b) frequency and dose of exposure; (c) dose-response relationships; (d) role of digestion, food processing, and the food matrix; (e) role of infection; (f) role of the gut microbiota; (g) influence of the structure and physicochemical properties of the protein; and (h) the genetic background and physiology of consumers. The consensus view is that sensitization screening models are not yet validated to definitively predict the de novo sensitizing potential of a novel protein. However, they would be extremely useful in the discovery and research phases of understanding the mechanisms of food allergy development, and may prove fruitful to provide information regarding potential allergenicity risk assessment of future products on a case by case basis. These data and findings were presented at a 2012 international symposium in Prague organized by the Protein Allergenicity Technical Committee of the International Life Sciences Institute's Health and Environmental Sciences Institute.
AB - Experimental in silico, in vitro, and rodent models for screening and predicting protein sensitizing potential are discussed, including whether there is evidence of new sensitizations and allergies since the introduction of genetically modified crops in 1996, the importance of linear versus conformational epitopes, and protein families that become allergens. Some common challenges for predicting protein sensitization are addressed: (a) exposure routes; (b) frequency and dose of exposure; (c) dose-response relationships; (d) role of digestion, food processing, and the food matrix; (e) role of infection; (f) role of the gut microbiota; (g) influence of the structure and physicochemical properties of the protein; and (h) the genetic background and physiology of consumers. The consensus view is that sensitization screening models are not yet validated to definitively predict the de novo sensitizing potential of a novel protein. However, they would be extremely useful in the discovery and research phases of understanding the mechanisms of food allergy development, and may prove fruitful to provide information regarding potential allergenicity risk assessment of future products on a case by case basis. These data and findings were presented at a 2012 international symposium in Prague organized by the Protein Allergenicity Technical Committee of the International Life Sciences Institute's Health and Environmental Sciences Institute.
UR - http://www.scopus.com/inward/record.url?scp=84978023494&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84978023494&partnerID=8YFLogxK
U2 - 10.1186/2045-7022-4-13
DO - 10.1186/2045-7022-4-13
M3 - Review article
C2 - 24739743
AN - SCOPUS:84978023494
SN - 2045-7022
VL - 4
JO - Clinical and Translational Allergy
JF - Clinical and Translational Allergy
IS - 1
M1 - 13
ER -